Beta-Thalassemia Terminated Phase 2 Trials for Deferiprone (DB08826)

Also known as: Beta-thalassemia / Thalassemia beta / Beta thalassemia / Beta thalassaemia / Beta thalassemia major / Thalassaemia beta / Beta-thalassaemia

IndicationStatusPhase
DBCOND0027982 (Beta-Thalassemia)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00115349Combination Therapy Compared With Single-Drug Therapy in Patients With Cardiac DiseasesTreatment